Cancer is rapidly becoming the top killer in the world. Most of the FDA approved anticancer
drugs are organic molecules, while metallodrugs are very scarce. The advent of the first …

Although cisplatin and its analogues have been widely utilized as anticancer metallodrugs
in clinics, their serious side effects and damage to normal tissues cannot be avoided …

Due to the increasing impact of cancer on worldwide mortality, more and more attention is
being devoted to the investigation of novel anticancer strategies. Among these …

Three water-soluble ruthenium (II) complexes with chiral 4-(2, 3-dihydroxypropyl)-formamide
oxoaporphine (FOA) were synthesized and characterized. It was found that these ruthenium …

Ruthenium (Ru) complexes are known for their promising anticancer activity presumably
due to octahedral coordination geometry, slow ligand exchange rate, the range of different …

G-quadruplexes have raised considerable interest during the past years for the development
of therapies against cancer. These noncanonical structures of DNA may be found in …

The design and characterization of new ruthenium (II) complexes aimed at targeting G‐
quadruplex DNA is reported. Importantly, these complexes are based on oxidizing 1, 4, 5, 8 …

Metal based salen complexes have been considered as an important scaffold toward
targeting of DNA structures. In the present work, we have synthesized nickel (II) and …

This review examines the existing knowledge about Ru (II)/(III) ion complexes with a
potential application in medicine or pharmacy, which may offer greater potential in cancer …

A series of dinuclear ruthenium (II) complexes were synthesised, and the complexes were
determined to be new highly selective compounds for binding to telomeric G‐quadruplex …